Literature DB >> 10816490

Expression of interleukin-1beta, tumor necrosis factor alpha, and interleukin-6 in human peripheral blood leukocytes exposed to human granulocytic ehrlichiosis agent or recombinant major surface protein P44.

H Y Kim1, Y Rikihisa.   

Abstract

Human granulocytic ehrlichiosis (HGE) is an emerging febrile systemic disease caused by the HGE agent, an obligatory intracellular bacterium of granulocytes. The pathogenicity- and immunity-related mechanisms of HGE are unknown. In this study, several cytokines generated in human peripheral blood leukocytes (PBLs) incubated with the HGE agent or a recombinant 44-kDa major surface protein (rP44) of the HGE agent were examined by reverse transcription-PCR and a capture enzyme-linked immunosorbent assay. The HGE agent induced expression of interleukin-1beta (IL-1beta), tumor necrosis factor alpha (TNF-alpha), and IL-6 mRNAs and proteins in PBLs in a dose-dependent manner to levels as high as those resulting from Escherichia coli lipopolysaccharide stimulation. The kinetics of induction of these three cytokines in PBLs by rP44 and by the HGE agent were similar. Proteinase K treatment of the HGE agent or rP44 eliminated the ability to induce these three cytokines. Induction of these cytokine mRNAs was not dependent on superoxide generation. These results suggest that P44 proteins have a major role in inducing the production of proinflammatory cytokines by PBLs. Expression of IL-8, IL-10, gamma interferon, transforming growth factor beta, and IL-2 mRNAs in response to the HGE agent was not remarkable. Among PBLs, neutrophils and lymphocytes expressed IL-1beta mRNA but not TNF-alpha or IL-6 mRNA in response to the HGE agent, whereas monocytes expressed all three of these cytokine mRNAs. These observations suggest that induction of proinflammatory-cytokine gene expression by the major outer membrane protein of the HGE agent in monocytes, which are not the primary host cells of the HGE agent, contributes to HGE pathogenesis and immunomodulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10816490      PMCID: PMC97610          DOI: 10.1128/IAI.68.6.3394-3402.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis.

Authors:  N Zhi; Y Rikihisa; H Y Kim; G P Wormser; H W Horowitz
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  Characterization of monoclonal antibodies to the 44-kilodalton major outer membrane protein of the human granulocytic ehrlichiosis agent.

Authors:  H Y Kim; Y Rikihisa
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Protein kinase A-mediated inhibition of gamma interferon-induced tyrosine phosphorylation of Janus kinases and latent cytoplasmic transcription factors in human monocytes by Ehrlichia chaffeensis.

Authors:  E H Lee; Y Rikihisa
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

4.  Immunoserologic evidence of Human Granulocytic Ehrlichiosis in Danish patients with Lyme neuroborreliosis.

Authors:  A M Lebech; K Hansen; P Pancholi; L M Sloan; J M Magera; D H Persing
Journal:  Scand J Infect Dis       Date:  1998

5.  Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family.

Authors:  N Ohashi; N Zhi; Y Zhang; Y Rikihisa
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

6.  Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases.

Authors:  H W Horowitz; M E Aguero-Rosenfeld; D F McKenna; D Holmgren; T C Hsieh; S A Varde; S J Dumler; J M Wu; I Schwartz; Y Rikihisa; G P Wormser
Journal:  Clin Infect Dis       Date:  1998-11       Impact factor: 9.079

7.  Mycobacterium avium-intracellulare complex activates nuclear transcription factor-kappaB in different cell types through reactive oxygen intermediates.

Authors:  D K Giri; R T Mehta; R G Kansal; B B Aggarwal
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

8.  Cloning and expression of the 44-kilodalton major outer membrane protein gene of the human granulocytic ehrlichiosis agent and application of the recombinant protein to serodiagnosis.

Authors:  N Zhi; N Ohashi; Y Rikihisa; H W Horowitz; G P Wormser; K Hechemy
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Human granulocytic ehrlichiosis--New York, 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-18       Impact factor: 17.586

10.  Human granulocytic ehrlichiosis in Europe: clinical and laboratory findings for four patients from Slovenia.

Authors:  S Lotric-Furlan; M Petrovec; T A Zupanc; W L Nicholson; J W Sumner; J E Childs; F Strle
Journal:  Clin Infect Dis       Date:  1998-09       Impact factor: 9.079

View more
  23 in total

1.  Polymorphism and transcription at the p44-1/p44-18 genomic locus in Anaplasma phagocytophilum strains from diverse geographic regions.

Authors:  Quan Lin; Yasuko Rikihisa; Robert F Massung; Zerai Woldehiwet; Richard C Falco
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

2.  The tick salivary protein sialostatin L2 inhibits caspase-1-mediated inflammation during Anaplasma phagocytophilum infection.

Authors:  Gang Chen; Xiaowei Wang; Maiara S Severo; Olivia S Sakhon; Mohammad Sohail; Lindsey J Brown; Mayukh Sircar; Greg A Snyder; Eric J Sundberg; Tyler K Ulland; Alicia K Olivier; John F Andersen; Yi Zhou; Guo-Ping Shi; Fayyaz S Sutterwala; Michail Kotsyfakis; Joao H F Pedra
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Anaplasma phagocytophilum delay of neutrophil apoptosis through the p38 mitogen-activated protein kinase signal pathway.

Authors:  Kyoung-Seong Choi; Joon Tae Park; J Stephen Dumler
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Early transcriptional response of human neutrophils to Anaplasma phagocytophilum infection.

Authors:  Bindu Sukumaran; Jason A Carlyon; Ji-Lian Cai; Nancy Berliner; Erol Fikrig
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Mechanisms of obligatory intracellular infection with Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

6.  Chromatin-bound bacterial effector ankyrin A recruits histone deacetylase 1 and modifies host gene expression.

Authors:  Kristen E Rennoll-Bankert; Jose C Garcia-Garcia; Sara H Sinclair; J Stephen Dumler
Journal:  Cell Microbiol       Date:  2015-06-11       Impact factor: 3.715

7.  Establishment of cloned Anaplasma phagocytophilum and analysis of p44 gene conversion within an infected horse and infected SCID mice.

Authors:  Quan Lin; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

8.  Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila.

Authors:  Hyung-Yong Kim; Jason Mott; Ning Zhi; Tomoko Tajima; Yasuko Rikihisa
Journal:  Clin Diagn Lab Immunol       Date:  2002-09

Review 9.  Molecular events involved in cellular invasion by Ehrlichia chaffeensis and Anaplasma phagocytophilum.

Authors:  Yasuko Rikihisa
Journal:  Vet Parasitol       Date:  2009-09-19       Impact factor: 2.738

10.  Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Authors:  Quan Lin; Ning Zhi; Norio Ohashi; Harold W Horowitz; Maria E Aguero-Rosenfeld; John Raffalli; Gary P Wormser; Yasuko Rikihisa
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.